CommentaryShould Patients Infected with Borrelia burgdorferi No Longer Be Referred to as Having Lyme Disease?
Section snippets
Acknowledgments
The author thanks Lisa Giarratano for her assistance.
References (18)
- et al.
Lyme borreliosis
Lancet.
(2012) - et al.
Chronic coinfections in patients diagnosed with chronic Lyme disease: a systematic review
Am J Med.
(2014) - et al.
Antiscience and ethical concerns associated with advocacy of Lyme disease
Lancet Infect Dis.
(2011) - et al.
False and misleading information about Lyme disease
Am J Med.
(2017) - et al.
Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities
Arthritis Rheum.
(1977) - et al.
Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum
Ann Intern Med.
(1977) - et al.
The spirochetal etiology of Lyme disease
N Engl J Med.
(1983) - et al.
The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America
Clin Infect Dis.
(2006) - et al.
Spirochetes isolated from the blood of two patients with Lyme disease
N Engl J Med.
(1983)
There are more references available in the full text version of this article.
Cited by (2)
Special Aspects of Lyme Borreliosis in the United States
2022, Lyme BorreliosisLyme borreliosis, ticks and Borrelia species
2018, Wiener Klinische Wochenschrift
Funding: GPW reports receiving research grants from Immunetics Inc, the Institute for Systems Biology, Rarecyte Inc, and Quidel Corporation.
Conflict of Interest: GPW owns equity in Abbott/AbbVie, has been an expert witness in malpractice cases involving Lyme disease and babesiosis, and is an unpaid board member of the American Lyme Disease Foundation.
Authorship: The author is solely responsible for the content of this manuscript.
© 2018 Elsevier Inc. All rights reserved.